Breath testing as a method for detecting lung cancer

Expert Review of Anticancer Therapy

Volumn 14, Issue 2, 2014, Pages 121-123

  Taivans, Immanuels ^a   Bukovskis, Maris ^a   Strazda, Gunta ^a   Jurka, Normunds ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

Author keywords

cancer diagnostics; cancer screening; electronic nose; exhaled breath analysis; lung cancer

Indexed keywords

BREATH TESTS; EARLY DETECTION OF CANCER; EXHALATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VOLATILE ORGANIC COMPOUNDS;

EID: 84893244017     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2013.866044     Document Type: Review

References (23)

1. American Cancer Society. Cancer Facts & Figures 2012. American Cancer Society, Atlanta, USA (2012).
2. Sing A, Freudenberg N, Kortsik C, et al. Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas. Acta Cytol. 41(2), 399-408 (1997).
3. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am. Rev. Respir. Dis. 130, 549-554 (1984).
4. Van de Kant KDG, van der Sande LJTM, Jöbsis Q, et al. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir. Res. 13, 117 (2012).
5. Horvath I, Lazar Z, Giulai N, et al. Exhaled biomarkers in lung cancer. Eur. Respir. J. 34, 261-275 (2009).
6. Van Berkel JJBN, Dallinga JW, Möller GM, et al. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 861, 101-107 (2008).
7. Hu YJ, Qiu YH, Chen EG, et al. Determination of volatile organic compounds in lung cancer cell lines and lung tissue. Zhejiang Da Xue Bao Yi Xue Ban 39(3), 278-84 (2010).
8. Sponring A, Filipac W, Mikowini T, et al. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res. 29, 419-426 (2009).
9. Mochalski P, Sponring A, King J, et al. Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro. Cancer Cell Int. 13, 72 (2013).
10. Haselbag S, Fleuren GJ, Baelde JJ, et al. Cytokine profile of cervical cancer cells, Gynocol. Oncol. 83(2), 235-243 (2001).
11. Yamamoto T, Kimura T, Ueta E, et al. Characteristic cytokine patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns. Oncology 64(4), 407-415 (2003).
12. Bhatanagar S, Kumar A. The TWEAKFn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Curr. Mol. Med. 12(1), 3-13 (2012).
13. Poli D, Carbogniani P, Corradi M, et al. Exhaled volatile organic compound in patients with non-small cell lung cancer: cross sectional and nested short-term followup study. Respir. Res. 6, 71 (2005).
14. Poli D, Goldoni M, Caglieri A. Breath analysis in non-small cell lung cancer patients after surgical tumour resection. Acta. Biomed. 79(Suppl. 1), 64-72 (2008).
15. Phillips M, Cataneo RN, Cummin ARC, et al. Detection of lung cancer with volatile markers in the breath. Chest 123(6), 2115 (2003).
16. Gardner JW, Bartlett PN. Electronic noses. Principles and applications. Meas. Sci. Technol. 11, 1087 (2000).
17. Mazzone PJ, Wang XF, Xu Y. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J. Thorac. Oncol. 7(1), 137-142 (2012).
18. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am. J. Respir. Crit. Care Med. 171, 1286-1291 (2005).
19. Dragonieri S, Annemaa JT, Schot R, et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64, 166-170 (2009).
20. Dragonieri S, van der Scheeb MP, Massaroc T, et al. An electronic nose distinguishes exhaled breath of patients with malignant pleural mesothelioma from controls. Lung Cancer 75, 326-331 (2012).
21. Peng G, Hakim M, Broza YY, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer 103, 542-551 (2010).
22. Strazda G, Bukovskis M, Kopeika U, et al. Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis. European Respiratory Society. Barcelona, Spain, 7-11 September 2013 (Poster 2891).
23. Basanta M, Ibrahim B, Dockry R, et al. Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respir. Res. 23(13), 72 (2012).